Experimental group:Apatinib Combined with Docetaxel

3 trials

Sponsors

Shanxi Provincial Hospital of Traditional Chinese Medicine, Shanxi Tumor Hospital

Conditions

lung cancer

Phase 2

Prospective, single-arm, single center, exploratory clinical study of Apatinib combined with Docetaxel as second line treatment in patients with advanced non-small cell lung cancer

RecruitingChiCTR-OIC-17013277

Shanxi Tumor Hospitallung cancer

Start: 2017-11-15Updated: 2017-11-13

Phase 4

Clinical Study for Sequential Chemotherapy with Apatinib in Patients with Non-small Cell Lung Cancer

RecruitingITMCTR1900002435

Shanxi Provincial Hospital of Traditional Chinese Medicinelung cancer

Start: 2017-03-01Updated: 2023-02-20

Clinical Study for Sequential Chemotherapy with Apatinib in Patients with Non-small Cell Lung Cancer

RecruitingChiCTR1900024189

Shanxi Provincial Hospital of Traditional Chinese Medicinelung cancer

Start: 2017-03-01Updated: 2019-07-01